ArticleIn vivo (Athens, Greece)
Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimLong-term outcomes after liver transplantation (LT) for hepatocellular carcinoma (HCC) vary widely, highlighting the need for reliable prognostic markers. This study evaluated the prognostic value of liver function-based metrics, namely albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI), for survival and recurrence post transplant. PATIENTS AND
methodsThis retrospective study included 69 adult patients with HCC who underwent LT between January 2004 and June 2025. Patients were stratified by ALBI and PALBI grade, and survival outcomes were compared using Kaplan-Meier analysis. Multivariate Cox regression models assessed the independent prognostic value of these measures.
resultsHigher ALBI and PALBI grades were associated with significantly worse OS and RFS (log-rank
conclusionThis two-decade study highlights the prognostic value of the pre-transplant ALBI and PALBI scores in predicting post-transplant survival and recurrence in patients with HCC. These scores, especially PALBI, provide objective assessments that enhance risk stratification and guide tailored postoperative surveillance strategies. Further validation in larger, multicenter studies is needed to confirm their clinical utility in the setting of LT after HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.